Earnings whiplash: Tesla’s $1T vote; Robinhood’s 100% rev; Palantir & Novo slip
News snapshot Volatile earnings tape today: big beats, surprise cuts, and one of tech’s highest‑stakes votes. From Robinhood’s 100% revenue jump to Tesla’s $1T pay showdown, sentiment is split. Quick hits: – Tesla (TSLA): Musk’s ~$1T pay package faces major investor/proxy pushback ahead of the vote; shares ~-3% on governance/dilution worries. – Robinhood (HOOD): Q3 […]
Brooks Nader candidly confesses she is ‘addicted’ to GLP-1 weight loss drug as she credits it to her ‘career taking off’ despite family concern
Brooks Nader revealed in a new interview that using a GLP-1 weight loss drug has contributed to her successful career.
The science of why your body resists weight loss
Research shows the battle to keep weight off isn’t about willpower—it’s biology. Here’s how scientists say we can work with our bodies, not against them. Losing weight is hard. More than half of Americans want to do so, but keeping it off is even harder. Research shows that 80 to 95 percent of people who […]
Novo Nordisk Presents Four New Analyses on Oral Semaglutide 25 mg (Wegovy® in a Pill) at ObesityWeek® 2025
Plainsboro, NJ and Bagsværd, Denmark, 5 November, 2025 – Novo Nordisk today presented new data from the OASIS 4 phase 3 trial that explored a variety of patients and hypotheses, adding to the body of evidence supporting this potential…
GLP-1 Agonists Tied to Lower Risk of Death in Dialysis Patients
(MedPage Today) — Use of GLP-1 receptor agonists was associated with a lower risk of mortality for dialysis patients with type 2 diabetes, according to a retrospective cohort study of Medicare enrollees. Among over 151,000 patients, use of GLP…
NEWBEAUTY LAUNCHES DIGITAL GLP-1 EDUCATION PLATFORM: STEP BEYOND THE SCALE
CRANBURY, N.J., Nov. 5, 2025 /PRNewswire/ — NewBeauty , the definitive authority on all things beauty, has announced a new GLP-1 education platform to support the growing demand for credible content on these medications. Step Beyond the Scale is the ultimate resource for those who are…
Inflection Point: How underappreciated critters inspired GLP-1 drugs
Hosts David and Gina explore the unexpected origins of blockbuster diabetes and weight-loss drugs like Ozempic and Wegovy
Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles
Novo Nordisk A/S NVO reported third-quarter 2025 earnings of 70 cents per American Depositary Receipt (ADR), which missed the Zacks Consensus Estimate of 77 cents. The company had reported earnings of 90 cents per ADR in the year-ago quarter. Revenues of $11.74 billion increased 5% year over year in the Danish kroner (DKK) and 11% at […]
Novo Nordisk Is Seeing Slowing Demand for GLP-1s Wegovy and Ozempic
Eric Thayer / Bloomberg via Getty Images Novo Nordisk lowered its guidance in part due to disappointing demand for Ozempic. Key Takeaways Novo Nordisk cut its outlook as it sees slowing demand for its GLP-1 weight loss and diabetes treatments. Third-quarter profit and revenue was short of analysts’ estimates. U.S.-listed shares of Novo Nordisk (NVO) […]
Can a weight loss and diabetes drug treat long COVID?
Scripps Research announced a new clinical trial Thursday that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID, the debilitating chronic condition diagnosed in an estimated 20 million Americans and about 400 million people worldwide. Developed to help people with type 2 diabetes control their blood […]